Dr. Scott Waldman obtained his PhD degree in Anatomy from Thomas Jefferson University, and his MD degree from Stanford University. He was a postdoctoral fellow at the University of Virginia and Stanford University in the Division of Clinical Pharmacology in the laboratory of Ferid Murad, MD, PhD, who won the 1998 Noble Prize in Physiology or Medicine.
Dr. Waldman is the Director of the Delaware Valley Institute for Clinical and Translational Research, the Director of the Gastrointestinal Cancer Program of the Kimmel Cancer Center, and the Chairman of the Department of Pharmacology and Experimental Therapeutics of Thomas Jefferson University. He is a past member of the American Board of Clinical Pharmacology, a past Regent of the American College of Clinical Pharmacology, and a past-President of the American Society for Clinical Pharmacology and Therapeutics.
He is the Editor-in-Chief for Clinical Pharmacology and Therapeutics, Biomarkers in Medicine, and the Deputy Editor-in-Chief for Clinical and Translational Science.
Dr. Waldman’s research interests focus on tissue-specific pathways underlying intestinal tumorigenesis and their utility as targets for managing patients with colorectal cancer.